Red flags / Dilution

SLSSELLAS Life Sciences Group Inc.ElevatedForm 424B5filed Nov 17, 4:14 PM ET

SELLAS Life Sciences files for $150 million common stock offering

SELLAS Life Sciences Group filed a preliminary prospectus supplement under its shelf registration for a $150,000,000 offering of common stock, with an option for underwriters to buy up to an additional $22,500,000 of shares over 30 days. The stock closed at $7.47 on November 16, 2026, and the final offering price and share count are not yet stated in the filing text. A stock sale of this kind dilutes existing shareholders and can add to pressure on the share price.

“We are offering shares of our common stock.”

What the stock did

From the last close before the filing was public. Market cap now: $2.8B.

1 day
-6.3%
SPY -0.3%
5 days
Not yet
 
20 days
Not yet
 

Prospectus supplement or shelf for new shares, including at-the-market programs. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on SLS

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 19, 4:07 PM ETSLS
SELLAS Life Sciences Group Inc.
Dilution
SevereForm 424B5
SELLAS Life Sciences to sell 11.5 million shares at $13.00 in $150 million offering$2.8B--